The Effect of Two Different Massages on Migraine

Headache, Migraine Clinical Trial

Official title:

Comparison of the Effectiveness of Connective Tissue Massage and Classical Massage in Patients With Migraine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05452330
• Other study ID #: Migren
• Status: Completed
• Phase: N/A
• Start date: July 18, 2022
• Est. completion date: September 16, 2022

Study information

• Verified date: July 2022
• Source: Biruni University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study aims to compare the effects of connective tissue massage on pain severity, attack frequency and duration, migraine-related disability, and quality of life in patients diagnosed with migraine, by comparing them with the classical massage.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: September 16, 2022
• Est. primary completion date: September 9, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Volunteers with a migraine diagnosis
• Taking only analgesics for migraine treatment and continuing their routines
• No problem in reading, writing and understanding Turkish

Exclusion Criteria:

• Having any other neurological problems
• Who had been injected with botulinum toxin in the last 3 months

Related Conditions & MeSH terms

• Headache
• Headache, Migraine
• Manuel Therapy
• Migraine Disorders

Intervention

Other:
• Connective tissue massage
Connective tissue massage will be applied with short and long pulling strokes to create a reflex effect for 2 days a week, a total of 8 weeks.
• Classical massage
Classical massage will be applied with the techniques of stroking, kneading, and friction for 2 days a week, a total of 8 weeks.

Locations

Country	Name	City	State
Turkey	Biruni University	Istanbul	Zeytinburnu

Sponsors (1)

Lead Sponsor	Collaborator
Biruni University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain Intensity	The intensity of pain perceived by the subjects will be evaluated with a valid method, the Visual Analogue Scale (VAS). The higher numbers show higher pain intensities.	8 weeks
Secondary	Migraine Related Disability	The Migraine Disability Assessment Scale (MIDAS), which is considered valid and reliable, will be used to evaluate the migraine-related disability. The higher scores indicate an increase in the severity of the disability.	8 weeks
Secondary	The Quality of Life	The patients' quality of life will be evaluated with the 24-hours Quality of Life in Migraine Scale (24-Hr-MQoLQ), which is valid and reliable. The increase in the score obtained from the scale indicates an increase in the quality of life.	8 weeks
Secondary	Perceived Patient-Reported Change	The change perceived by the patients after the intervention will be evaluated with the Global Rating of Change Scale (GROC). According to the scale, it is expressed as "-2: I am much worse, -1: I am worse, 0: No change, 1: I am better, 2: I am much better".	8th week (one week)
Secondary	The general descriptive demographic information	The general descriptive demographic information of the participants such as age and gender; migraine family history, duration of the complaints, attack frequency and duration will be questioned with a form prepared by the researchers.	8 weeks